DEACONESS WOMENS HOSPITAL — History
CCN 150149 | 3-year financial timeline | COVID resilience: 51/100
🛡️ Public data only — no PHI permitted on this instance.
$128M
Latest Revenue (FY2022)
+6.3%
Revenue CAGR (3yr)
9.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $114M | $126M | $128M | +2.1% | +6.3% |
| Operating Expenses | $98M | $108M | $116M | +7.5% | +9.0% |
| Operating Margin | 14.1% | 14.3% | 9.8% | -31.7% | -16.8% |
| Net Income | $16M | $18M | $13M | -30.3% | -11.6% |
| Licensed Beds | 74 | 74 | 74 | +0.0% | +0.0% |
| Total Patient Days | 22,988 | 23,537 | 22,915 | -2.6% | -0.2% |
| Medicare Day % | 0% | 0% | 1% | +65.9% | +14.7% |
| Medicaid Day % | 8% | 8% | 12% | +57.9% | +19.3% |
COVID Impact & Recovery
Resilience Score: 51/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +13.0% ($114M → $128M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+6.3%
This Hospital
+7.6%
State Avg
Latest Margin
9.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $136M | 7.6% |
| FY2024 (proj) | $143M | 5.4% |
| FY2025 (proj) | $151M | 3.2% |